Singapore markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.68-0.52 (-5.10%)
At close: 04:00PM EDT
9.51 -0.17 (-1.76%)
After hours: 06:39PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-135,117
-135,117
-279,818
-303,659
-166,411
Depreciation & amortisation
3,504
3,504
5,496
4,731
4,628
Deferred income taxes
-32.046
-32.046
0
0
0
Stock-based compensation
11,072
11,072
22,555
26,337
15,648
Change in working capital
-10,260
-10,260
19,834
50,351
-71,072
Accounts receivable
9,333
9,333
-3,706
11,032
-17,015
Accounts payable
-45,989
-45,989
32,607
26,141
3,251
Other working capital
-124,686
-124,686
-217,185
-216,940
-179,500
Other non-cash items
155.814
155.814
186.977
858.644
2,364
Net cash provided by operating activities
-124,366
-124,366
-216,215
-215,709
-177,979
Cash flows from investing activities
Investments in property, plant and equipment
-320.898
-320.898
-969.153
-1,231
-1,521
Acquisitions, net
0
0
-2,000
0
-1,400
Purchases of investments
-203,475
-203,475
-248,529
-348,953
-156,217
Sales/maturities of investments
284,933
284,933
361,084
174,840
62,991
Other investing activities
-
-
-
-
-2,775
Net cash used for investing activities
87,356
87,356
109,586
-175,344
-58,796
Cash flows from financing activities
Common stock issued
5,462
5,462
82,955
209,441
454,486
Other financing activities
-466.646
-466.646
-1,398
-4,611
-1,648
Net cash used provided by (used for) financing activities
4,995
4,995
81,841
211,499
465,280
Net change in cash
-32,018
-32,018
-24,814
-179,584
228,532
Cash at beginning of period
46,329
46,329
71,144
250,728
22,196
Cash at end of period
14,311
14,311
46,329
71,144
250,728
Free cash flow
Operating cash flow
-124,366
-124,366
-216,215
-215,709
-177,979
Capital expenditure
-320.898
-320.898
-969.153
-1,231
-1,521
Free cash flow
-124,686
-124,686
-217,185
-216,940
-179,500